Contemporary Approaches in IVF in Clinical Decision-Making

Abstract

Assisted reproductive technology (ART), particularly in vitro fertilization (IVF), has undergone significant evolution over the past decade, incorporating advances in laboratory techniques, patient selection, and personalized medicine. This review explores contemporary approaches in IVF, emphasizing clinical decision-making guided by recent evidence and guidelines. We discuss the epidemiology of infertility, pathophysiology influencing IVF success, risk factor assessment, diagnostic criteria, and a spectrum of therapeutic strategies. Special focus is placed on emerging technologies such as preimplantation genetic testing, time-lapse embryo imaging, and personalized ovarian stimulation protocols, as well as their clinical implications for optimizing outcomes and minimizing risks. The article synthesizes current practice recommendations and offers insights for clinicians to individualize care for improved pregnancy rates and patient safety.

Introduction

In vitro fertilization (IVF) represents a cornerstone of assisted reproductive technology, offering hope to couples experiencing infertility. The decision-making process in IVF has transitioned from standardized approaches to highly individualized care, integrating patient-specific factors, molecular diagnostics, and evolving therapeutic modalities. This shift is driven by a deeper understanding of reproductive physiology, improved laboratory techniques, and a growing emphasis on safety and efficacy. For clinicians, staying abreast of these developments is essential for delivering optimal patient outcomes. This article reviews the current landscape of IVF, highlighting contemporary strategies that inform clinical decisions in practice.

Epidemiology / Disease Burden

Infertility affects approximately 8-12% of reproductive-aged couples globally, with increasing prevalence attributed to delayed childbearing, lifestyle factors, and rising rates of certain medical conditions. IVF cycles are performed worldwide, with over 2.5 million cycles annually and more than 500,000 resulting live births. The burden is not only medical but also psychosocial and economic, emphasizing the need for efficient, evidence-based care pathways. Epidemiological trends show a steady rise in demand for IVF, underscoring the necessity of refined clinical frameworks for patient selection and management.

Pathophysiology

The pathophysiology underlying infertility and the need for IVF is multifactorial. Female factors include diminished ovarian reserve, tubal pathology, endometriosis, and ovulatory disorders, while male factors range from impaired spermatogenesis to obstructive azoospermia. Molecular mechanisms such as mitochondrial dysfunction, chromosomal aberrations, and epigenetic alterations impact gamete quality and embryo development. Understanding these mechanisms aids in tailoring interventions—such as selecting between conventional IVF and intracytoplasmic sperm injection (ICSI)—and optimizing protocols for ovarian stimulation and embryo culture.

Risk Factors

Several risk factors influence IVF outcomes, including advanced maternal age, obesity, smoking, environmental exposures, and underlying medical disorders like polycystic ovary syndrome (PCOS) and thyroid dysfunction. Prior reproductive history, ovarian reserve markers (AMH, AFC), and semen parameters also modulate prognosis. Recognizing these factors is crucial for pre-treatment counseling, protocol selection, and setting realistic expectations for patients.

Clinical Features

Patients presenting for IVF may report primary or secondary infertility, with a history often revealing irregular menstruation, pelvic pain, or known male factor infertility. Clinical evaluation encompasses a thorough reproductive, medical, and surgical history, as well as assessment of reproductive anatomy via ultrasound, hysterosalpingography, or laparoscopy as indicated. Laboratory investigations for hormonal milieu, ovarian reserve, and infectious status are routine, forming the basis for individualized management plans.

Diagnosis

The diagnostic approach in IVF candidates involves confirmation of infertility (failure to conceive after 12 months of unprotected intercourse), assessment of female and male reproductive function, and exclusion of reversible causes. Key diagnostic tools include transvaginal ultrasound for antral follicle count, serum anti-Müllerian hormone (AMH) for ovarian reserve, semen analysis, and tubal patency assessment. Genetic screening may be indicated in recurrent pregnancy loss or severe male factor cases.

Treatment & Management

IVF treatment is a multi-step process: controlled ovarian stimulation (COS), oocyte retrieval, fertilization (conventional or ICSI), embryo culture, and embryo transfer. Protocols for COS are tailored based on ovarian reserve and patient characteristics, aiming to maximize oocyte yield while minimizing ovarian hyperstimulation syndrome (OHSS). Luteal phase support, embryo transfer timing, and number of embryos transferred are individualized to balance efficacy with the risk of multiple gestations. Adjuncts such as preimplantation genetic testing (PGT), endometrial receptivity assays, and adjuvant therapies (e.g., low-dose aspirin, heparin) are considered in select populations.

Recent Advances / Emerging Therapies

Contemporary IVF practice integrates a range of innovative technologies. Time-lapse imaging allows for continuous embryo monitoring, facilitating more accurate selection for transfer. PGT enables detection of aneuploidy or monogenic disorders, improving implantation rates and reducing miscarriage risk. Personalized stimulation protocols—using gonadotropin dosing algorithms and GnRH antagonist regimens—reduce OHSS risk and improve outcomes in poor or high responders. Artificial intelligence (AI) applications in embryo selection and laboratory quality control are emerging, with early evidence suggesting enhanced predictive accuracy. Non-invasive embryo assessment methods, such as spent culture media analysis, are under investigation, aiming to further refine selection without compromising embryo integrity.

Guideline Recommendations

Professional guidelines from ESHRE, ASRM, and NICE emphasize individualized patient assessment, judicious use of adjunctive technologies, and shared decision-making. Recommendations include limiting the number of embryos transferred to reduce multiple pregnancy risk, elective single embryo transfer in favorable prognosis patients, and routine use of luteal phase support. The use of PGT is advised in selected cases based on age, recurrent pregnancy loss, or known genetic disorders. Regular audit of laboratory and clinical outcomes is encouraged to ensure quality and safety.

Conclusion

Contemporary IVF practice is characterized by a personalized, evidence-based approach that leverages advances in reproductive biology, laboratory science, and clinical medicine. Clinicians should remain vigilant to evolving guidelines and emerging technologies, integrating them thoughtfully to optimize patient outcomes. Ongoing research promises further refinement of protocols and greater success rates, while minimizing risks associated with ART. Collaborative, patient-centered care remains essential for translating scientific progress into improved reproductive health.